We face enormous challenges: chronic and infectious diseases, obesity, dementia, cancer and First Nations health. National Health and Medical Research Council (NHMRC) CEO Professor Steve Wesselingh says the answers are in innovation, research and discovery. Professor Wesselingh was at TRI today for a building tour, fireside chat with early career researchers and our Game Changer seminar, providing insights into NHMRC priorities for addressing pressing threats to human health globally. He has pointed to advances in genetics, vaccine development, AI, artificial organs and robotics in underpinning evidence-based research – while retaining ethics, integrity and creativity. He also spoke of partnering with industry and consumers, engaging with the Indigenous community, building workforce capacity and gender equity, and bolstering community confidence in research - en route to translation and commercialisation.
Translational Research Institute Australia
Research
Woolloongabba, QLD 12,887 followers
An Australian-first bench-to-bedside medical research institute, translating medical discoveries into improved health.
About us
The TRI is a medical research institute based in Brisbane, Australia, interfacing directly with hospital clinicians, government and industry to improve the success of scientific discoveries translated into real treatments and diagnostics for improved health outcomes.
- Website
-
http://www.tri.edu.au
External link for Translational Research Institute Australia
- Industry
- Research
- Company size
- 501-1,000 employees
- Headquarters
- Woolloongabba, QLD
- Type
- Nonprofit
- Founded
- 2012
- Specialties
- medical research, teaching, cervical cancer, breast cancer, prostate cancer, melanoma, liver and kidney disease, osteoporosis, obesity, diabetes, immunology, and immunotherapy
Locations
-
Primary
37 Kent Street
Woolloongabba, QLD 4102, AU
Employees at Translational Research Institute Australia
Updates
-
Congratulations to the TRI-based finalists in the Life Sciences Queensland Ltd (LSQ) #GENEAwards2024, recognising excellence and achievement in the sector. TRI CEO Professor Scott Bell for the McCullough Robertson Industry Excellence Award. SPARQ-ed (https://lnkd.in/gu72YEqD) for the Merck Life Science Rural and Regional Service Award. Microbio for the Cytiva Company of the Year Award. Dr Iris Depaz from Sanofi for the Industry Excellence Award and QIMR Berghofer Medical Research Institute Woman of Influence Award. Professor Ranjeny Thomas from The University of Queensland #FrazerInstUQ for the Woman of Influence Award. Dr Nathalie Bock from QUT (Queensland University of Technology) for the The Rose-Anne Kelso Commemorative Award, created by Stockwell and LSQ. Infensa Bioscience for the KE Select - Scientific & Medical Recruitment Specialists Emerging Innovator Award. Read more: https://lnkd.in/gCb98cPX
-
-
Thank you to Dr Flavia Huygens from Microbio, Emeritus Professor Ian Frazer from The University of Queensland and Associate Professor Helen Benham from TRI for involvement in a piece written about us for Collaborate magazine. The piece covers our collaborations, our support of medtech firms such as Microbio, and our plans for the game-changing biomedical manufacturing facility due to open in 2026. Read online: https://lnkd.in/g4mxg-aF Mater Research Queensland Health Metro South Health Children's Health Queensland Hospital and Health Service QUT (Queensland University of Technology)
-
-
This might look like just another construction site but it’s so much more. Why? It’s our Australian first advanced biomedical manufacturing facility, TM@TRI. This pioneering project is proudly funded by the Queensland Government and TRI. It will nurture Aussie med-tech innovators and help them develop and manufacture their products in Australia, without having to go offshore. Here at TRI, we’re really proud of this visionary concept and so today’s final major concrete pour on the ground floor is something we and Australia’s biotech industry are celebrating. To follow the site progress, visit https://bit.ly/3UDDBdo #medtech #research #biotech #innovation #translationalmanufacturing
-
REMINDER: Registrations closing soon. Looking for ways to progress your R&D pipeline plus secure additional research funding? Secure your organisation’s spot to be matched with medical research collaborators in TRI’s ACTIVATE program. Learn more and register at https://bit.ly/3zORXR9
Looking to collaborate with top academic and clinical researchers?
-
TRI is proud to have hosted Australian Chief Scientists for high-level discussions on topics including research and development, infrastructure and STEM in schools. The forum also provided an opportunity to showcase TRI, our role in the Boggo Road Innovation Precinct, and the construction of our translational manufacturing facility to support biotechs in scale-up for testing and developing their products. Thank you, Dr Cathy Foley (Australia), Dr Susie Meade (New Zealand), Professor Kerrie Wilson (Qld), Dr Darren Saunders (NSW), Hugh Maclachlan and Dr Jade Redfern-Podger (ACT), Dr Amanda Caples (Vic), Chief Scientist for South Australia Professor Craig Simmons, Martin Redhead (NT) and Professor Peter Klinken (WA).
-
-
TRI is a major player in the Boggo Road Innovation Precinct, fostering an ecosystem of talent and global connections across health, biomedical and environmental sciences. Connections are not formed with a flick of a switch. AusBiotech and Griffith University Institute for Biomedicine and Glycomics have brought together experts to talk about shaping the future of such precincts. TRI's Glenda Colburn joined a panel with experts from Sanofi, University of the Sunshine Coast, QUT (Queensland University of Technology) and Southern RNA 🧬to cover topics including researcher-clinician engagement, clinical trials, navigating a complex regulatory environment, space and tenancy issues. Queensland Government Department of Environment, Science and Innovation QIC The University of Queensland Thermo Fisher Scientific Gold Coast Health and Knowledge Precinct Springfield City Group Griffith University Metro North Health
-
-
Thank you to all who presented at TRI's cancer metabolism mini-symposium today: Lisa Philp, Lisa Butler, Jenni Gunter, Julia Pagan, Megan Crichton, Henry Lamb, Naomi Berrell and Prahlad Raninga, between them representing University of Adelaide, The University of Queensland, Mater Research, QUT (Queensland University of Technology), Queensland Spatial Biology Centre (QSBC) and #FrazerInstUQ. We heard about: - challenges, such as current treatment side effects, relapse and therapy resistance - research into tumour microenvironments, spacial biology, metabolism and links to the gut microbiome - hope that comes from advances in immunotherapy, peptide therapeutics, targeted therapies and nutrition.
-
-
Collaboration is the name of the game. Dr Joshua Tobin is among the clinicians and scientists to have presented at a TRI networking event focusing on haematology. Princess Alexandra Hospital haematologists and TRI-based researchers working on blood cancers used the event to explore potential collaborative research projects, with support from TRI experts, facilities and funding schemes. Metro South Health The University of Queensland Mater Research QUT (Queensland University of Technology)
-
-
TRI is joining global imaging experts in Denmark in September, exploring ways to combine technologies that will boost medical research from cancer and immunology to bone and tissue regeneration. Dr Brian Tse from TRI Preclinical Imaging is one of only 24 experts to take part in the Molecule to Human Boot Camp. Read more: https://lnkd.in/gbiWHtWu Euro-BioImaging Chan Zuckerberg Initiative Danish BioImaging African BioImaging Consortium Africa Microscopy Initiative Assn of Biomolecular Resource Facilities (ABRF) CAMERA MRI Africa Latin America Bioimaging
-